Carregant...
Therapeutic monitoring of amikacin and gentamicin in critically and noncritically ill patients
OBJECTIVE: Therapeutic drug monitoring (TDM) enables individualization in the treatment to optimize clinical benefit and minimize drugs' side effects. Critically ill septic patients represent a challenge for antimicrobial treatment because of pathophysiological impact of sepsis on pharmacokinet...
Guardat en:
| Publicat a: | J Basic Clin Pharm |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Medknow Publications & Media Pvt Ltd
2016
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4910469/ https://ncbi.nlm.nih.gov/pubmed/27330257 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/0976-0105.183260 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|